Paralytics

Neuromuscular-blocking agents also known as paralytics block neuromuscular transmission at neuromuscular junction, causing loss of motion of skeletal muscles. This is accomplished similarly by acting presynaptically through the inhibition of acetylcholine (ACh) synthesis and by acting postsynaptically at the acetylcholine receptors of the motor nerve end-plate. While a few medications act presynaptically, (for example, botulinum toxin and tetanus poison), those of current clinical significance work postsynaptically. Because the appropriate dose of neuromuscular-blocking medication may paralyze muscles required for breathing (i.e., the diaphragm), mechanical ventilation should to be provided to maintain adequate respiration.

 

    Related Conference of Paralytics

    October 14-15, 2019

    12th World Congress on Anesthesiology and Critical Care

    Holiday Inn Singapore Atrium | Singapore
    November 11-12, 2019

    2nd World Congress on Surgeons

    Istanbul, Turkey
    November 18-19, 2019

    4th International Anesthesia and Pain Medicine Conference

    Bali, Indonesia
    November 21-22, 2019

    World Congress on Orthopedics & Rheumatology

    Singapore
    November 25-26, 2019

    World conference on Osteoarthritis and Its Complications

    Sydney,Australia
    March 30-31, 2020

    11th International Congress on Surgery

    Kyoto, Japan
    May 15-16, 2020

    14th International Meeting on Anaesthetics & Sedatives

    Sydney, Australia
    June 10-11, 2020

    Anesthesia 2020

    Frankfurt, Germany
    August 24-26, 2020

    5th European Otolaryngology-ENT Surgery Conference

    Barcelona, Spain
    September 14-15, 2020

    10th World Congress on Frontiers in Plastic Surgery

    | Tokyo, Japan

    Paralytics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in